top of page

Remicade (infliximab)

The recommended dose of REMICADE® is 5 mg/kg given as an IV induction regimen at 0, 2, and 6 weeks followed by a maintenance regimen of 5 mg/kg IV every 8 weeks thereafter for the treatment of adults with moderately to severely active Crohn's disease.

Remicade (infliximab)

LSG Infusion Services

Outpatient Infusion Services

349 East Northfield Road

Suite 200

Livingston, NJ 07039

Telephone: 973-597-0900

Fax: 973-597-0910

Serving Greater New York Metropolitan Area

Infusion Hours by Appointment: To schedule a patient, contact our "Infusion Care Coordinator".

bottom of page